COVID-19 UPDATES AS ON 18.9.2020

 

Ministry of Health and Family Welfare

COVID-19 Update

Centre rushes High Level Central team to Jammu

Central team to assist in strengthening Containment, Surveillance, Testing and efficient Clinical Management

Posted On: 18 SEP 2020 3:10PM by PIB Delhi

Ministry of Health and Family Welfare has decided to depute a high level Central team to Jammu. The district has reported a rise in the number of new COVID cases in the recent days.

The team comprises of Dr. S K Singh, Director, National Centre for Disease Control (NCDC) and Dr. Vijay Hadda, Associate Professor, Dept. of Pulmonary Critical Care, AIIMS, New Delhi.

It may be recalled that a special team had visited the Srinagar valley recently. The two-member high level team was led by Dr V K Paul, Member (Health), NITI Aayog and Dr S K Singh, Director, NCDC was its member. The team had reviewed the status of preparedness for COVID management with the District Collectors of the valley. The current Central team shall interact with the District Collectors and Health Officers of Jammu. It shall also visit hospitals in Bakshinagar and Gandhinagar.

The team will support the State efforts towards strengthening containment, surveillance, testing and efficient clinical management of the positive cases. The Central team shall also guide in effectively managing the challenges related to timely diagnosis and follow up.

The total number of confirmed COVID cases in Jammu is 9428. Of these, 3196 have recovered. COVID deaths are reported to be 117. There are 6115 Active Cases in the district. The total cases one week ago were 6878. Jammu has been reporting Doubling Time of 15.4 days, Recovery Rate of 33.9% and CFR of 1.24%.

As an ongoing effort to strengthen efforts of various State/UT Governments for COVID management, the Central Government has been deputing Central teams from time to time to visit various States/UTs. These teams interact with the State/UT authorities and get a first hand understanding of the challenges and issues being faced by them so as to strengthen their ongoing activities and remove bottlenecks, if any.  

****

MV

HFW/COVID Central team-Jammu/18September2020/2

(Release ID: 1656139) Visitor Counter : 71

Ministry of Health and Family Welfare

Availability of Medical Colleges

Posted On: 18 SEP 2020 4:16PM by PIB Delhi

At present, there are 541 medical colleges (280 under Government and 261 under Private) in the country with an intake capacity of 80,312 MBBS seats annually. The State-wise number of medical college is given below:

 

MBBS
State Name	Total Colleges	Govt. Colleges	Private Colleges
Andaman & Nicobar Islands	1	1	0
Andhra Pradesh	31	13	18
Arunachal Pradesh	1	1	0
Assam	7	7	0
Bihar	16	10	6
Chandigarh	1	1	0
Chhattisgarh	10	7	3
Dadra and Nagar Haveli	1	1	0
Delhi	10	8	2
Goa	1	1	0
Gujarat	29	17	12
Haryana	12	5	7
	7	6	1
Jammu & Kashmir	8	7	1
Jharkhand	7	7	0
Karnataka	60	19	41
Kerala	31	10	21
Madhya Pradesh	22	14	8
Maharashtra	56	25	31
Manipur	2	2	0
Meghalaya	1	1	0
Mizoram	1	1	0
Odisha	12	8	4
Puducherry	9	2	7
Punjab	10	4	6
Rajasthan	23	15	8
Sikkim	1	0	1
Tamil Nadu	50	26	24
Telangana	33	11	22
Tripura	2	1	1
Uttar Pradesh	55	26	29
Uttarakhand	6	4	2
West Bengal	25	19	6
Total	541	280	261

 

The number of medical colleges have increased by around 45% over the last six years. Number of medical colleges in 2014 was 381. The number of MBBS seats have also increased by 48% over the last six years from 54,348 in 2014 to 80,312 in 2020. The Government is implementing a Centrally Sponsored Scheme to establish new medical colleges attached with District/Referral hospitals in underserved areas of the Country. 157 new medical colleges have been approved under the scheme of which 43 have already become functional.

As on date, in the case of government medical colleges, the respective State governments are responsible for fixation of fee and in the case of private unaided medical colleges, the fee structure is decided by a Committee set up by the respective State Government under the Chairmanship of a retired High Court Judge in pursuance of the directions of the Hon’ble Supreme Court of India. It is for the Committee to decide whether the fee proposed by an Institute is justified and the fee fixed by the Committee is binding on the Institute.

Further, clause (i) of Sub-section (1) of Section 10 of National Medical Commission Act, 2019 provides for framing of guidelines for determination of fees and all other charges in respect of fifty percent of seats in private medical institutions and deemed to be universities which are governed under the provisions of the Act.

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656183) Visitor Counter : 42

Ministry of Health and Family Welfare

Early Detection Centres for Cancer

Posted On: 18 SEP 2020 4:17PM by PIB Delhi

The information regarding estimated incidence of cancer cases in the country is based on National Cancer Registry Programme (NCRP) of Indian Council of Medical Research. The latest report of NCRP is for the year 2020, which is based on data for the period 2012-16, as compared to earlier report of 2016, which was based on data for the period 2012-14. Also, the year 2020 report is based on an increased coverage in terms of more number of Population Based Cancer Registries (PBCRs) or expansion of some existing PBCRs. As a result of above changes, the annual figures of estimated incidence of cancer in the country in the year 2020 report have undergone revision as compared to previous report of NCRP of 2016, and the revised year-wise figures are as under:

Year	2017	2018	2019
Estimated Incidence of Cancer Cases	12,92,534	13,25,232	13,58,415

 

 

Public Health and Hospitals is a State subject. The Central Government, however, supplements the efforts of the State Governments to prevent and control cancer and to provide affordable and accessible care. The Government is implementing National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), with focus on strengthening infrastructure, human resource development, health promotion & awareness generation, early diagnosis, management and referral to an appropriate level institution for treatment.

Under NPCDCS, Population level initiative for prevention, control and screening for common NCDs (diabetes, hypertension and common cancers viz. oral, breast and cervical cancer) is also being implemented across the country including Lakshadweep. Financial assistance is also provided to the Government of Lakshadweep through Programme Implementation Plan (PIP) for population based screening including early detection of cancer. Under this initiative, persons above 30 years of age are targeted for screening for common NCDs by trained frontline workers at Heath & Wellness Centres/ Primary Health Centres/ Sub-centres. Screening of common NCDs including three common cancers i.e. oral, breast and cervical is also an integral part of service delivery under Ayushman Bharat - Health and Wellness Centres. Population based screening helps in mass awareness generation about risk factors and early detection of NCDs including common cancers. UT Administration of Lakshadweep has informed that Primary Health Centre (PHC) Kalpeni, PHC Kiltan, PHC Chetlath have been converted to Health & Wellness Centres and cancer screening has been initiated in these islands. Further, the UT Administration organized mass screening campaign for early detection of carcinoma breast, oral cancers and cervical cancers for eligible population at island of Amni.

Awareness campaigns on common risk factors for NCDs, including cancer, and for promotion of healthy lifestyle are also carried out through print, electronic and social media. Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR), Noida, has launched www.cancerindia.org  with the theme “India Against Cancer”, a portal that provides information on the leading cancers in India with a major focus on awareness, prevention and treatment of these cancers.

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

*****

MV

(Release ID: 1656185) Visitor Counter : 16

 

Ministry of Health and Family Welfare

Assessment of COVID Prevention

Posted On: 18 SEP 2020 4:17PM by PIB Delhi

World Health Organization, Country office, India alerted India on 6^th January, 2020 about outbreak of pneumonia of unknown origin in Wuhan city of China. WHO issued a statement on 9^th January, 2020 about a novel coronavirus, which was later named as SARS-CoV-2 virus and the disease was named COVID-19 by WHO on 11^th February, 2020.

The first Indian case of COVID-19 was reported on 30^th January 2020. Before the Nationwide lockdown, a series of actions were undertaken in a pro-active, graded and pre-emptive manner based on the evolving scenario.

To prevent entry of disease, India started point of entry screening of passengers at ports, airports and land border crossings on 18th January, 2020 to identify symptomatic travelers from affected countries. Subsequently universal screening was done for all passengers. Integrated Disease Surveillance Programme followed up these international travelers in the community and contacts of suspects and confirmed cases. In all such States/Districts that reported cases, a containment strategy was followed to contain clusters and large outbreaks. Travel advisories and guidelines on surveillance, contact tracing, sample collection & transportation, clinical management, discharge policy, infection prevention & control and home quarantine were also issued.

The details are as under:

 

Date	Cases	Deaths
23-03-2020	451	9
01-09-2020	3691166	65288

 

Between 16-23^rd March most of the State Governments/UTs resorted to partial or full lockdown in their respective State/UTs based upon their assessment of the situation.

COVID-19 is a highly infectious disease. There was a need for consistency in the approach & implementation in a scientific manner to prevent the spread of the virus and break/suppress the chain of transmission.

Taking into consideration the above facts, the global experience and the needs for consistency in approach and implementation of various containment measures across the country, a Nationwide lockdown was announced on 24^th March, 2020 to contain the spread of COVID-19 in the country.

By imposing country-wide lock-down, India successfully blunted the aggressive progression of COVID. The period of lockdown helped the nation create much required additional health infrastructure. During this time, dedicated isolation beds recorded an increase of 22 times and dedicated ICU beds above 14 times to what existed in March 2020. Similarly, laboratory capacity for testing COVID was increased nearly 10 times during this time. Whereas there was no indigenous manufacturing of PPE and N-95 masks, with the requisite standards, at that point in time, we are now self-sufficient and, in a position, to export the same. Similarly, very limited indigenous manufacturing ventilators was available at the time of lockdown, this capacity was also enhanced to attain self-reliance in this regard.

During this period, various cadres of personnel and volunteers across sectors and departments for COVID related works and maintenance of other essential medical services were worked out, trained through resources made available on the website of MoHFW, iGOT (online platform) by DOPT (https://igot.gov.in/igot/).

It has been estimated that the decision of lockdown by slowing down the progress of pandemic in India, prevented 14–29 lakh cases and 37–78 thousand deaths.

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656184) Visitor Counter : 21

Ministry of Health and Family Welfare

Delay in Surgeries Due to Corona

Posted On: 18 SEP 2020 4:19PM by PIB Delhi

There have been reports in the media regarding planned surgeries being cancelled/affected due to Covid-19 pandemic. However, Public Health & Hospitals being State subjects, such information is not maintained centrally.

As far as three Central Government Hospitals in Delhi viz. Safdarjung, Dr. Ram Manohar Lohia (RML) and Lady Hardinge Medical College (LHMC) & Associated Hospitals, are concerned, elective operation theatres were closed w.e.f. 18.03.2020 and elective surgeries resumed w.e.f. 01.09.2020 in Safdarjung Hospital. However, during the period of March, 2020 to 10.09.2020, a total number of 3356 numbers of emergency surgeries were done in Safdarjung Hospital.

In Dr. RML Hospital, planned surgeries were curtailed during COVID-19 for initial period of two months. As the norms of lockdown were relaxed, planned surgeries were resumed in a sequential manner. However, during the entire COVID period, emergency surgeries were never stopped and round the clock emergency surgeries were performed as and when required. No planned surgeries were cancelled or delayed in LHMC & Associated Hospitals. All emergency surgeries are being operated with proper screening of the COVID-19 pandemic. Further, separate operations theatres were earmarked for surgery of suspected and confirmed cases.

As far as All India Institute of Medical Sciences (AIIMS), New Delhi is concerned, some of the elective surgeries were postponed due to COVID-19. However, all emergency surgeries were undertaken regularly without any delay. Approximately 5958 surgeries of non COVID patients have been performed during the period from 25.03.2020 to 31.08.2020.

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656186) Visitor Counter : 21

 

Ministry of Health and Family Welfare

COVID Cases and Sero Survey Status

Posted On: 18 SEP 2020 4:20PM by PIB Delhi

India has one of the lowest cases per million population. It is 3445 for India as compared to 19295 for USA, 20146 for Brazil, 7283 for Russian Federation and 10929 for South Africa. However, cases per million population for India is high as compared to other countries in South East Asia

 

The low case fatality in India can be attributed to early case detection through community-based surveillance, containment measures including strict perimeter control, house-to-house case search & follow-up with  monitoring of oxygen saturation, early referral to COVID treatment facilities and adequate case management.

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656187) Visitor Counter : 31

 

Ministry of Health and Family Welfare

Procedure for Research on Vaccine

Posted On: 18 SEP 2020 4:21PM by PIB Delhi

The Central Drugs Standard Control Organisation (CDSCO) has informed that the requirements and guidelines to conduct clinical trial or grant of permission for marketing of new drugs including vaccines are prescribed under New Drugs and Clinical Trials Rules, 2019.

Further, the Indian Council of Medical Research (ICMR), an autonomous organisation of the Department of Health Research, has informed that the stages of vaccine development include the following steps:

 

i. Identification and development of an appropriate vaccine strain which may be safe and immunogenic.

ii. Full characterization of the vaccine strain by in-vitro experiments.

iii. Pre-clinical studies in small animals like rats, mice, rabbits, guinea pigs, hamsters etc. These are safety and dose determination studies.

iv. Preclinical studies in large animals (depending upon feasibility and availability) to determine safety, protective efficacy and potential dose and formulation.

v. Phase I human clinical trials which establish the safety of the product. The numbers are usually < 100.

vi. Phase II human clinical trials to determine the immunogenicity or immune protection. The numbers are usually < 1000.

vii. Phase III human clinical trials to determine the efficacy. The numbers range in several thousands. After successful completion of phase III studies, regulatory approval is accorded.

viii. Phase IV or post marketing surveillance studies.

 

CDSCO has informed that it has not received any report regarding such deviation from the standard procedures in research and development of vaccine for Coronavirus.

Central Drugs Standard Control Organisation (CDSCO) has informed that it has granted test license permission for manufacture of COVID-19 Vaccine for preclinical test, examination and analysis to the following manufacturers in India:

1.        M/s Serum Institute of India Pvt., Ltd., Pune

2.        Ms. Cadila Healthcare Ltd., Ahmadabad

3.        M/s Bharat Biotech International Ltd., Hyderabad

4.        Biological E Ltd., Hyderabad

5.        M/s Reliance Life Sciences Pvt Ltd., Mumbai

6.        M/s Aurbindo Pharma Limited, Hyderabad

7.        M/s Gennova Biopharmaceuticals Limited, Pune

The Indian Council of Medical Research (ICMR), an autonomous organisation under the Department of Health Research, has informed that it is facilitating the following studies related to COVID-19 vaccines:

 

(i) An inactivated whole virion candidate vaccine (BBV152) for SARS-CoV-2 has been developed by Bharat Biotech International Ltd (BBIL) using the virus isolate (NIV-2020-770) provided by ICMR-National Institute of Virology (NIV), Pune. Characterization of the vaccine candidate has been undertaken at ICMR-NIV followed by safety and tolerability studies in small animals like rats, mice and rabbits. Status of clinical trials is as follows:

·                                 Phase I clinical trials along with parallel studies in hamsters and rhesus macaques have been completed. The trial has revealed excellent safety of the candidate vaccine. Immunogenicity testing is in progress.

·                                 Phase II clinical trials are ongoing.

(ii) A DNA vaccine (ZyCov-D) has been developed by Cadila Healthcare Ltd. Pre- clincial toxicity studies were conducted in small animals: mice, rats, rabbits and guinea pigs. The vaccine has been found to be safe and immunogenic. Cadila has partnered with ICMR for conduct of parallel pre-clinical studies in rhesus macaques. Status of clinical trials is as follows:

·                                 Phase I clinical trials have been completed. The trial has revealed excellent safety of the candidate vaccine. Immunogenicity testing is in progress.

·                                 Phase II clinical trials are ongoing.

(iii) Serum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates:

·                                 ChAdOx1-S, which is a non- replicating viral vector vaccine developed by University of Oxford/AstraZeneca. This vaccine is undergoing phase III clinical trials in Brazil. Phase II/III bridging studies have been initiated by ICMR at 14 clinical trial sites. ICMR-National Institute for Research in Tuberculosis (NIRT), Chennai is the lead institution.

·                                 ICMR and SII have also partnered for clinical development of a glycoprotein subunit nanoparticle adjuvanted vaccine developed by Novavax from USA. The trial will be initiated in second half of October after the vaccine is manufactured by SII. The trial is led by ICMR-National AIDS Research Institute (NARI), Pune.

           As per details provided by Department of Biotechnology (DBT)/Department of Science and Technology (DST), more than 30 vaccine candidates have been supported which are in different stages of development.

 

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656188) Visitor Counter : 51

 

Ministry of Health and Family Welfare

Primary Health Centres (PHCs)

Posted On: 18 SEP 2020 4:22PM by PIB Delhi

Under the National Health Mission (NHM), Primary Health Centre (PHC) are established to cover a population of 30,000 in rural areas and 20,000 in hilly, tribal and desert areas.

PHCs are established to cover defined population. As per the Rural Health Statistics-2019, as on 31.03.2019, a total of 24,855 rural PHCs and 5,190 urban PHCs have been functional in the country. State-wise details including for Rajasthan are given below:

NUMBER OF PRIMARY HEALTH CENTRES (PHCs) FUNCTIONING IN RURAL AND URBAN AREAS

(As on 31.03.2019)

Sr. No.	State / UT	PRIMARY HEALTH CENTRES (PHCs)
		Rural	Urban	Total
1	Andhra Pradesh	1,145	364	1,509
2	Arunachal Pradesh	143	4	147
3	Assam	946	55	1,001
4	Bihar	1,899	95	1,994
5	Chhattisgarh	792	45	837
6	Goa	24	0	24
7	Gujarat	1,476	318	1,794
8	Haryana	379	97	476
9	Himachal Pradesh	586	20	606
10	Jammu & Kashmir	622	49	671
11	Jharkhand	298	57	355
12	Karnataka	2,127	435	2,562
13	Kerala	848	83	931
14	Madhya Pradesh	1,199	136	1,335
15	Maharashtra	1,828	538	2,366
16	Manipur	90	9	99
17	Meghalaya	118	0	118
18	Mizoram	59	10	69
19	Nagaland	126	5	131
20	Odisha	1,288	87	1,375
21	Punjab	416	16	432
22	Rajasthan	2,082	377	2,459
23	Sikkim	29	1	30
24	Tamil Nadu	1,422	463	1,885
25	Telangana	636	249	885
26	Tripura	108	5	113
27	Uttarakhand	257	0	257
28	Uttar Pradesh	2,936	624	3,560
29	West Bengal	908	448	1,356
30	Andaman & Nicobar Islands	22	2	24
31	Chandigarh	0	46	46
32	Dadra & Nagar Haveli	9	2	11
33	Daman & Diu	4	0	4
34	Delhi	5	535	540
35	Lakshadweep	4	0	4
36	Puducherry	24	15	39
TOTAL – ALL INDIA		24,855	5,190	30,045

 

State-wise details of State Program Implementation Plan approvals for the Primary   Health Centers under NHM for the years 2017-18 to 2020-21 are given below:

 

 

Details of SPIP Approvals for the PHCs under NHM for the FY 2017-18 to 2020-21

 

(Rs. in Lakhs)

Sl. No.	Name of the State/UT	2017-18	2018-19	2019-20	2020-21
High Focus States
1	Bihar	500.00	10,508.85	5,766.94	3,225.00
2	Chhattisgarh	976.86	3,317.94	1,996.62	1,260.38
3	Himachal Pradesh	727.01	738.80	2,024.48	---
4	Jammu & Kashmir	949.01	745.00	597.68	---
5	Jharkhand	1,242.00	1,245.00	1,739.96	1,381.96
6	Madhya Pradesh	2,658.00	---	610.00	8,509.59
7	Orissa	2,678.91	740.00	1,433.57	5,160.69
8	Rajasthan	14,331.00	7,524.12	23,329.83	---
9	Uttar Pradesh	832.83	37.50	412.89	120.00
10	Uttarakhand		16.00	5.56	19,657.62
	Sub Total	24,895.62	24,873.21	37,917.53	39,315.24
B.  NE States
11	Arunachal Pradesh	584.57	356.06	544.80	1,464.54
12	Assam	1,794.48	1,024.33	1,777.06	540.00
13	Manipur	---	126.70	770.50	---
14	Meghalaya	---	9.00	70.50	---
15	Mizoram	100.00	84.00	114.38	286.44
16	Nagaland	107.37	102.30	33.97	---
17	Sikkim	262.32	307.63	358.19	1,840.00
18	Tripura	3,537.26	2,140.50	1,272.00	4,235.98
	Sub Total	6,386.00	4,150.52	4,941.40	8,366.96
C. Non-High Focus States
19	Andhra Pradesh	---	---	130.00	21.00
20	Goa	10.50	1.50	---	---
21	Gujarat	874.00	383.50	1,049.29	---
22	Haryana	---	7.00	75.00	200.00
23	Karnataka	5,337.50	6,368.50	4,154.63	1,202.49
24	Kerala	428.00	581.00	821.31	17,243.82
25	Maharashtra	1,1602.02	9,955.00	18,181.77	---
26	Punjab	300.00	---	---	3,005.00
27	Tamil Nadu	2,927.50	976.25	3,465.90	---
28	Telangana	200.00	630.00	---	---
29	West Bengal	417.75	2,295.75	3,205.81	22,392.31
	Sub Total	22,097.27	21,198.50	31,083.71	44,064.62
D. Small States/UTs
30	Andaman & Nicobar Islands	16.00	8.00	---	---
31	Chandigarh	---	---	---	---
32	Dadra & Nagar Haveli	---	---	---	---
33	Daman & Diu	---	---	---	---
34	Delhi	---	---	---	---
35	Lakshadweep	---	---	---	1,399.11
36	Puducherry	20.00	---	---	---
	Sub Total	36.00	8.00		1,399.11
	Grand Total	53,414.89	50,230.23	73,942.63	93,145.93

 

Note: -

1.        SPIP stands for State Program Implementation Plan.

2.        The above figures are as reported by the States /UTs.

3.        The above figures are inclusive of activity Additional Building/Major Upgradation of existing Structure, Upgradation, Spill over of Ongoing Works, new constructions, Staff Quarters, carry forward of new construction initiated last year, or the year before and major civil works for operationalization of 24 hour services at Primary Health Centres (PHCs).

 

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656190) Visitor Counter : 27

 

Ministry of Health and Family Welfare

Recruitment of Ayurvedic Medical Officers in AIIMS

Posted On: 18 SEP 2020 4:28PM by PIB Delhi

AIIMS Bhubaneswar has conducted recruitment for Ayurvedic Medical Officers in which 01 post of Senior Medical Officer (Ayurveda) and 02 posts of Medical Officer (Ayurveda) were advertised against which 01 post of Senior Medical Officer (Ayurveda) and 02 posts of Medical Officer (Ayurveda) were filled up.  However, one candidate resigned from the post of Medical Officer (Ayurveda) and current filled up position stands at 01 post of Senior Medical Officer (Ayurveda) and 01 post of Medical Officer (Ayurveda).

The notification for the said posts was published vide advertisement dated 22.02.2016 in the News papers, Employment News as well as in the Institute’s website. The applications were sought through ONLINE mode only. The applications received were duly scrutinized by the Screening Committee constituted by the Director, AIIMS Bhubaneswar. After scrutiny, the lists of eligible & non-eligible candidates were uploaded in the Institute’s website. Further, written tests for each post were conducted and on the basis of the performance in the written tests, candidates were called for personal interview, the candidates were recommended by the Selection Committee for appointment to the posts strictly as per the merit. The Governing Body (GB) of the Institute approved their selection, accordingly the offer of appointments were issued to them.

It has been informed by the Institute that no complaint pertaining to the recruitment exercise has been received in the Institute. However, as per records available with the Ministry, one complaint on irregularities in the said recruitment exercise was received. However, no supporting documents were found with the complaint and the complaint did not bear any address to verify the authenticity. As per DoPT guidelines, such complaints are classified as anonymous complaints

The criteria adopted for formation of selection panel was as per the MoHFW guidelines dated 01.05.2015. Accordingly, a selection committee was formed with the approval of the competent authority, AIIMS Bhubaneswar.

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656195) Visitor Counter : 23

 

Ministry of Health and Family Welfare

People affected by COVID-19

Posted On: 18 SEP 2020 4:30PM by PIB Delhi

The total number of people affected, recovered and died due to COVID-19 is given below :

State/UT wise details of number of total COVID-19 cases, active cases, recovered cases and deaths (as on 16-09-2020)

S. No.	Name of State / UT	Total Cases	Active cases	Recovered/ Discharged/ Migrated cases	Deaths
1	Andaman & Nicobar Islands	3574	204	3318	52
2	Andhra Pradesh	583925	92353	486531	5041
3	Arunachal Pradesh	6466	1795	4658	13
4	Assam	146575	29180	116903	492
5	Bihar	160871	13055	146980	836
6	Chandigarh	8592	2991	5502	99
7	Chhattisgarh	70777	35909	34279	589
8	Dadra & Nagar Haveli and Daman & Diu	2783	229	2552	2
9	Delhi	225796	29787	191203	4806
10	Goa	25511	5102	20094	315
11	Gujarat	116183	16357	96582	3244
12	Haryana	98622	20430	77166	1026
13	Himachal Pradesh	10335	3801	6444	90
14	Jammu and Kashmir	56654	18678	37062	914
15	Jharkhand	64439	14118	49750	571
16	Karnataka	475265	98555	369229	7481
17	Kerala	114033	31226	82341	466
18	Ladakh	3499	938	2517	44
19	Madhya Pradesh	93053	21620	69613	1820
20	Maharashtra	1097856	292174	775273	30409
21	Manipur	8210	1745	6418	47
22	Meghalaya	4036	1818	2190	28
23	Mizoram	1480	558	922	0
24	Nagaland	5229	1269	3945	15
25	Odisha	158650	32267	125738	645
26	Puducherry	20601	4674	15522	405
27	Punjab	84482	21154	60814	2514
28	Rajasthan	105898	16761	87873	1264
29	Sikkim	2173	464	1690	19
30	Tamil Nadu	514208	46806	458900	8502
31	Telengana	162844	30401	131447	996
32	Tripura	20150	7498	12435	217
33	Uttarakhand	34407	10739	23230	438
34	Uttar Pradesh	324036	67335	252097	4604
35	West Bengal	209146	23942	181142	4062
36	India (Total)	5020359	995933	3942360	82066

 

For appropriate management of COVID-19 cases, a three tier arrangement of health facilities [(i) COVID Care Center with isolation beds for mild or pre-symptomatic cases; (ii) Dedicated COVID Health Centre (DCHC) with oxygen supported isolation beds for moderate cases and (iii) Dedicated COVID Hospital (DCH) with ICU beds for severe cases] has been implemented. Tertiary care hospitals under ESIC, Defence, Railways, paramilitary forces, Steel Ministry etc. have been leveraged for case management. In addition, Defence Research and Development Organisation (DRDO) has set up large field hospitals with capacities ranging from 1000 to 10,000 isolation beds.

The availability of beds in various districts is monitored by Ministry of Health and Family Welfare. Based on the growth rate trajectory, States are conveyed the requirement to enhance capacity in advance and followed up through letters and video conferences.

Government of India has taken a number of other steps to contain/mitigate the impact of Covid Pandemic that applies to all sections of society. India followed a whole of Government and whole of society approach. Hon’ble Prime Minister, a High level Group of Ministers (GoM), Cabinet Secretary, Committee of Secretaries and senior officers in MoHFW continue to monitor public health response to COVID-19 in the country.

The public health actions were taken in a pre-emptive, pro-active, graded manner based on the evolving scenario. A number of travel advisories were issued restricting inflow of international travelers, till such time, commercial flights were suspended on 23rd March, 2020. Till then, a total of 14,154 flights with 15,24,266 passengers have been screened at these airports. Screening was also done at 12 major and 65 minor ports and land border crossings. In the initial part of the pandemic, India evacuated a large number of stranded passengers from then COVID affected countries (China, Italy, Iran, Japan, Malaysia) and again in the un-lockdown phase, a total of 13,18,891 passengers have been brought back (as on 14th September, 2020) and followed up.

Integrated Disease Surveillance Programme (IDSP) is conducting contact tracing through community surveillance. In the earlier part of the pandemic, this was done for travel related cases and subsequently for cases being reported from community as a part of containment strategy. As on 14th September 2020, a total of about 40 lakh persons have been kept under surveillance. There are 726 laboratories conducting COVID-19 Testing. India is testing is about 1 million samples a day. A total of 5.8 crore samples have been tested so far (as on 14th September 2020).

States are being supported in terms of supply of logistics. So far 1.41 Crore of PPE Kits, 3.44 crores N-95 masks, 10.84 crore tablets of Hydroxychloroquine and 30,663 ventilators and 1,02,400 oxygen cylinders have been supplied to States/UTs/ Central Government hospitals so far (as on 14th September, 2020).

Various cadres of personnel and volunteers across sectors and departments for COVID related works and maintenance of other essential medical services have been worked out, trained through resources made available on the website of MoHFW, iGOT (online platform) by DOPT (https://igot.gov.in/igot/).

MoHFW website is being daily to provide general public with information on current status of COVID-19 spread in India. Communication material is also being hosted on MoHFW website and through social media. A dedicated call centre / helpline (1075) has been started to guide community at large which are being used by the citizens very effectively and on a regular basis.

More than 30 vaccine candidates have been supported which are in different stages of development, 3 candidates are in advanced stage of Phase I/II/III trials and more than 4 are in advanced pre-clinical development stage. A National Expert Group on Vaccine Administration for COVID-19 has been constituted on 7th August, 2020, under NITI Aayog. Thirteen clinical trials of repurposed drugs have been undertaken to build a portfolio of therapeutic options for Covid-19 patients.

Further, financial assistance to States/UTs has been given based on the number of cases and trends of COVID-19 Pandemic. Accordingly, all the States/ UTs are provided with necessary financial support under India COVID-19 Emergency Response and Health System Preparedness Package. States /UTs were given flexibility to use the resources available under NHM to prepare the public healthcare system for COVID-19 management.

During FY 2020-21, funds of Rs 4256.79 crore have been released to the States/ UTs as on 10.09.2020 and the State wise amount allocated and released to each State/UT is given below:

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656199) Visitor Counter : 29

 

Ministry of Health and Family Welfare

Tele-Medicine Platform for Health Care Delivery

Posted On: 18 SEP 2020 4:33PM by PIB Delhi

Public health is a state subject. Under the National Health Mission (NHM), support is being provided to States/UTs to strengthen their healthcare systems including Tele-consultation services based on requirements posed by the States in their Programme Implementation Plans (PIPs).     

 

eSanjeevani Telemedicine solution developed by CDAC-Mohali is being rolled out under Ayushman Bharat – Health & Wellness Centres program.

 

Under Ayushman Bharat, 1.5 lakh Sub Health Centres (SHCs) and rural and urban Primary Health Centres (PHCs) across the country are being transformed by December 2022 as Health and Wellness Centres (AB-HWCs) with an aim to provide Comprehensive Primary Health Care (CPHC) that includes preventive and health promotion at the community level with continuum of care.

The state- wise details of funds approved under NHM for Tele-consultation for FY 20-21 are given below:

 

State-wise details of funds approved under NHM for Tele-consultation at Ayushman Bharat Health and Wellness Centres

 

Sl. No.	State	Total Amount Approved for Tele-Consultation in FY 20-21 (Rs. in lakh) as on 15.09.20
1	Andaman & Nicobar Islands	0
2	Andhra Pradesh	69.55
3	Arunachal Pradesh	63.2
4	Assam	33.84
5	Bihar	683.53
6	Chandigarh	0
7	Chhattisgarh	487.25
8	Dadra & Nagar Haveli	0
9	Daman & Diu	0
10	Delhi	NIL
11	Goa	13.47
12	Gujarat	15.84
13	Haryana	1069.31
14	Himachal Pradesh	575.37
15	Jammu & Kashmir	158.4
16	Jharkhand	14.69
17	Karnataka	2187.68
18	Kerala	0
19	Ladakh	0
20	Lakshadweep	0
21	Madhya Pradesh	1513.75
22	Maharashtra	346.44
23	Manipur	0
24	Meghalaya	7.92
25	Mizoram	31.4
26	Nagaland	21.08
27	Odisha	200.16
28	Puducherry	58.29
29	Punjab	293.2
30	Rajasthan	794.4
31	Sikkim	28.5
32	Tamil Nadu	553.2
33	Telangana	216.34
34	Tripura	99.69
35	Uttar Pradesh	649.32
36	Uttarakhand	0
37	West Bengal	3.6
	TOTAL STATES	10189.42

 

eSanjeevani has been implemented at around 3000 HWCs.

For providing technical assistance to States, NHM had issued ‘Guidelines for Tele-Medicine Services in Ayushman Bharat - Health and Wellness Centres (HWCs)’ providing details of implementation model, IT infrastructure required at hubs & spokes, human resource required for conducting telemedicine etc. to States. Accordingly States/UTs are submitting proposals seeking financial support under NHM.

 

CDAC has been providing regular technical assistance to States for training, handholding and for ensuring uninterrupted operations of the services.       

The list of Hospitals/Health Centers connected through telemedicine in country is available on ministry website at https://main.mohfw.gov.in/node/5158 .

 

The eSanjeevani application has been modelled on EHR guidelines issued by MoHFW, GoI. The application is compatible with advance technologies like Internet-of-Things (IoT) and bluetooth enabled diagnostic devices. The whole architecture of eSanjeevani is based on the agile framework and utilizes cloud services for hosting.

eSanjeevani is being continuously upgraded to be compatible with advanced telemedicine tools for betterment of services.

The modalities regarding integration of Tel-cardiology and Tele-radiology services are being examined in consultation with States and CDAC.

Telemedicine implementation at Health & Wellness Centers (spokes) linked with doctors (Hubs) has helped to address the shortage of  doctors and other healthcare professionals, as telemedicine enables the access of specialist services from hubs to patient from nearby HWC through eSanjeevani.

However, Govt. of India / Board of Governors in supersession of Medical Council of India issued ‘Telemedicine Practice Guidelines’ in March 2020.

eSanjeevani telemedicine service is being rolled out in 1.5 Lakh Health & Wellness Centers (HWCs) under Ayushman Bharat programme in all States/UTs.

States are being supported under NHM for IT initiatives based on the requirement posed by States in PIP.

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656201) Visitor Counter : 22

 

Ministry of Health and Family Welfare

Treatment of Non-COVID-19 Patients During Pandemic

Posted On: 18 SEP 2020 4:34PM by PIB Delhi

The patients who were not suffering from Corona but still have been treated in AIIMS and Central Government run hospitals in IPD as well as in OPD after 24^th March, 2020 in the country is given in Annexure.

As per the National Health Accounts (NHA) Estimates 2016-17 (latest available), public expenditure on health  as a percentage of GDP is 1.2%.

No such patient who was already admitted in AIIMS or Central Government run hospitals whether serious/critical or non-serious was discharged from the hospitals without adequate treatment, due to pandemic situation in the country.

 

S.No.	Name of the Hospital	No. of patients treated since 24.3.2020
1.	AIIMS, New Delhi	401506
2.	Safdarjung Hospital, New Delhi	253220
3.	RML Hospital, New Delhi	268471
4.	LHMC, New Delhi	211796
5.	AIIMS, Bhubaneswar	94999
6.	AIIMS, Jodhpur	127631
7.	AIIMS, Raipur	126486
8.	AIIMS, Rishikesh	48765
9.	AIIMS, Patna	15491
10.	AIIMS, Bhopal	62862

 

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.

 

*****

MV

(Release ID: 1656205) Visitor Counter : 57